BUSINESS

Asia Stocks Plunge as US-Iran Threats Escalate, Oil Surges on Strait of Hormuz Fears

Dow Jones Futures Plunge Over 600 Points as Weak Jobs
Asian stock markets tumbled sharply Monday amid escalating threats between the United States and Iran, as the conflict entered its fourth week with no signs of de-escalation. Major indexes in Japan and South Korea fell more than 5%, driven by investor fears over potential disruptions to global energy supplies through the Strait of Hormuz.

FTSE 100 Today: UK Blue-Chip Index Closes at 9,918.33 After 1.44% Slide as Investors Digest Geopolitical Risks

FTSE 100
LONDON — The FTSE 100 ended lower on Friday, March 20, 2026, closing at 9,918.33, down 145.17 points or 1.44%, marking its largest single-day percentage decline in recent weeks amid profit-taking and broader market caution. The benchmark index opened at 10,063.25 but quickly retreated, trading in a range of 9,915.70 to 10,127.56 before settling near session lows on volume of approximately 2.61 billion shares.
More news
Executive Elevation: What can you learn from an MBA?

Executive Elevation: What can you learn from an MBA?

For professionals already operating in the world of business, the question is rarely what an MBA is and more pointedly, what an MBA can actually teach me that experience hasn't already.
Banco Bradesco

Banco Bradesco (BBD) Stock Holds Steady Near $4.11 After Strong 2025 Results

Banco Bradesco S.A.'s American depositary receipts have traded in a tight range around $4.11 in late February 2026, closing at $4.11 on February 24 after a 0.98% gain, as the Brazilian lender builds on robust 2025 profitability and a multi-year transformation plan that has lifted return on equity and efficiency metrics.
Itaú Unibanco Holding

Itaú Unibanco (ITUB) Stock Climbs to $9.33 on Record ROE, Digital Gains After Q4 2025 Beat

Itaú Unibanco Holding S.A.'s American depositary receipts have shown steady gains in February 2026, closing at $9.33 on February 24 after rising 1.74%, as the Brazilian banking giant capitalizes on a record return on equity, successful digital transformation, and a renewed share buyback program amid resilient loan growth and improved efficiency.
ImmunityBio

ImmunityBio (IBRX) Stock Explodes 500%+ in 2026 on ANKTIVA's 700% Revenue Surge

ImmunityBio Inc.'s stock has skyrocketed in early 2026, surging more than 500% year-to-date and hitting new 52-week highs above $11 as explosive sales growth for its flagship immunotherapy ANKTIVA, coupled with rapid international regulatory approvals and partnerships, fuels investor enthusiasm for the cancer-focused biotech.

Pages

  • Prev
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next